National Holdings (NHLD) 3.10 $NHLD
Tonix Pharmaceuticals Completes $10 Million Public Offering of Common Stock
GlobeNewswire - Tue Jun 21, 11:00AM CDT
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), today announced the closing of its previously announced underwritten public offering of 5,000,000 shares of its common stock. The shares were sold at the public offering price of $2.00 per share, bringing the aggregate gross proceeds from the offering to $10 million, before deducting underwriting discounts and commissions and other offering expenses. The financing was led by healthcare focused institutional investors.
TNXP: 2.16 (+0.03), NHLD: 3.10 (+0.02)
Champions Oncology, Inc. Announces Closing of Public Offering of Common Stock
PR Newswire - Wed Jun 15, 11:00AM CDT
Champions Oncology, Inc. (NASDAQ: CSBR), or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the closing of its previously announced underwritten public offering of 2,000,000 registered shares of its common stock, par value $0.001 per share, at an offering price of $2.25 per share. In addition, the Company announced today the partial exercise of the over-allotment option granted to the underwriter to purchase an additional 258,749 shares of its common stock at the public offering price. All of the shares have been offered by the Company. The shares of Champions Oncology, Inc. are currently trading on NASDAQ under the symbol "CSBR".
CSBR: 2.22 (+0.02), NHLD: 3.10 (+0.02)
Champions Oncology, Inc. Announces Pricing of Public Offering of Common Stock
PR Newswire - Thu Jun 09, 6:30PM CDT
Champions Oncology, Inc. (NASDAQ: CSBR), or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the pricing of its previously announced underwritten public offering. The Company is offering 2,000,000 registered shares of its common stock, par value $0.001 per share, at an offering price of $2.25 per share. In addition, Champions Oncology, Inc. has granted the underwriter a 45-day over-allotment option to purchase up to 300,000 additional shares of common stock at the public offering price. All of the shares are being offered by the Company. The shares of Champions Oncology, Inc. are currently trading on NASDAQ under the symbol "CSBR".
CSBR: 2.22 (+0.02), NHLD: 3.10 (+0.02)
Interstate Batteries and Aqua Metals Form Strategic Partnership
GlobeNewswire - Thu May 19, 7:30AM CDT
Aqua Metals, Inc. (NASDAQ:AQMS) (Aqua Metals), which is commercializing a non-polluting electrochemical lead recycling technology called AquaRefining(TM), today announced the signing of definitive agreements with Interstate Batteries. Interstate Batteries is the No. 1 replacement battery brand, the largest independent battery distribution system in North America and the country's leading battery recycler.
AQMS: 12.20 (+0.29), NHLD: 3.10 (+0.02)
Scott K. Stucky Appointed Executive Vice-President of Software & Data Services at SettlementOne
PR Newswire - Wed May 18, 7:17AM CDT
Sackett National Holdings, Inc. (SNH), a leading provider of lending data, energy, employment screening and automotive products and services, today announced that Scott K. Stucky has been appointed Executive Vice-President, Software & Data Solutions, for SNH financial subsidiary SettlementOne.
NHLD: 3.10 (+0.02)
National Holding Corporation Announces Fiscal Second Quarter 2016 Financial Results
BusinessWire - Mon May 16, 4:01PM CDT
National Holding Corporation (NASDAQ:NHLD) ("National" or the "Company"
, a leading full service independent brokerage, investment banking and asset management firm providing diverse services including tax preparation & accounting services, today announced its financial results for the fiscal second quarter 2016 ended March 31, 2016.
NHLD: 3.10 (+0.02)
National Holdings Corporation Schedules Fiscal 2016 Second Quarter Earnings Release and Conference Call
BusinessWire - Wed May 11, 7:00AM CDT
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company" announced today that it will report its fiscal 2016 second quarter financial results on Monday, May 16, 2016 after the close of the financial markets. Management will host a conference call to discuss the operating and financial results and take investor questions at 9:00am ET on Tuesday, May 17, 2016.
NHLD: 3.10 (+0.02)
Fortress Biotech Reports First Quarter 2016 Financial Results and Recent Corporate Highlights
GlobeNewswire - Tue May 10, 4:10PM CDT
Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress", a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced its financial results and recent corporate highlights for the quarter ended March 31, 2016.
FBIO: 2.89 (+0.15), NHLD: 3.10 (+0.02)
Fortress Biotech and National Holdings Announce Agreement
Marketwired - Thu Apr 28, 7:50AM CDT
National Holdings Corporation (NASDAQ: NHLD) ("National Holdings" or "NHLD", a full-service investment banking and asset management firm, and Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress" or "FBIO", a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, announce today that the two firms have entered into a definitive agreement (the "Agreement" pursuant to which Fortress will offer to purchase, through its wholly owned subsidiary, FBIO Acquisition, Inc., up to 100% of the shares of National Holdings at $3.25 per share in cash. The offer price represents a premium of ~44% over the closing price of NHLD common stock on April 27, 2016, the last trading day prior to today's announcement.
FBIO: 2.89 (+0.15), NHLD: 3.10 (+0.02)
Resonant Inc. Announces Closing of Private Placement Raising Approximately $6 million in Gross Proceeds
BusinessWire - Tue Apr 26, 6:30AM CDT
Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced it has closed its previously announced private placement of units (the Offering) with various institutional and individual accredited investors and certain of the Company's officers and directors. Resonant raised gross proceeds of approximately $6 million in the Offering.
RESN: 4.07 (-0.04), NHLD: 3.10 (+0.02)
Resonant Inc. Announces Signing of Securities Purchase Agreement to Raise up to $6 Million in Gross Proceeds
BusinessWire - Fri Apr 22, 6:30AM CDT
Resonant Inc. (NASDAQ: RESN), a developer of innovative filter designs for radio frequency front-ends (RFFEs) for the mobile device industry, today announced it has entered into a definitive agreement with various institutional and individual accredited investors and certain of its officers and directors to raise gross proceeds of up to $6 million in a private placement of units at a per-unit price of $2.985 (the Offering).
RESN: 4.07 (-0.04), NHLD: 3.10 (+0.02)
Imprimis Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
PR Newswire - Wed Mar 16, 3:05PM CDT
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), ("Imprimis" or the "company", a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, announced today that it has completed the previously announced public offering of common stock. Imprimis sold 2.9 million shares in the offering and an additional 435,000 common shares upon the full exercise by the underwriters of their over-allotment option. The offering price was $3.60 per share, and the gross proceeds to Imprimis from the sale of shares, including the over-allotment option, were $12 million, before deducting underwriting expenses.
NHLD: 3.10 (+0.02), IMMY: 3.85 (+0.05)
Imprimis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
PR Newswire - Fri Mar 11, 7:45AM CST
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), ("Imprimis" or the "company", a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, announced today the pricing of an underwritten public offering of 2.9 million shares of its common stock at a price to the public of $3.60 per share, before underwriting discounts. In addition, the company has granted the underwriters the option, exercisable for 45 days, to purchase an additional 435,000 shares of its common stock to cover over-allotments. The offering is expected to close on or about March 16, 2016, subject to satisfaction of customary closing conditions.
NHLD: 3.10 (+0.02), IMMY: 3.85 (+0.05)
Imprimis Pharmaceuticals Announces Proposed Public Offering of Common Stock
PR Newswire - Thu Mar 10, 3:05PM CST
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), ("Imprimis" or the "company", a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, announced today a proposed underwritten public offering of its common stock, subject to market and other conditions. In connection with the offering, the company intends to grant the underwriters the option, exercisable for 45 days, to purchase additional shares equal to up to 15% of the aggregate number of shares sold in the offering to cover over-allotments.
NHLD: 3.10 (+0.02), IMMY: 3.85 (+0.05)
National Holdings Corporation Comments on Acquisition Offers
BusinessWire - Wed Jan 27, 8:00AM CST
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company", a full-service investment banking and asset management firm, provided the following comments regarding the two acquisition offers it had previously received during the final two months of 2015.
NHLD: 3.10 (+0.02)
National Holdings expands its Investment Banking team with three investment bankers
M2 - Mon Jan 11, 7:27AM CST
National Holdings Corporation (NASDAQ:NHLD) revealed on Friday that it hired three investment bankers, Sagiv Shiv, S Quintus von Bonin and Ivan Saval to expand its M&A and advisory services capabilities.
NHLD: 3.10 (+0.02)
National Holdings Corporation Expands Its Investment Banking Team
BusinessWire - Fri Jan 08, 8:00AM CST
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company", a full-service investment banking and asset management firm, announced today that it has hired three investment bankers, Sagiv Shiv, S. Quintus von Bonin and Ivan Saval, greatly expanding its M&A and advisory services capabilities in order to continue to better serve our corporate clients and their needs. All of the bankers were previously employed by INTL FCStone Financial Inc., the securities business of INTL FCStone Inc. and collectively bring 75 years of industry experience to the Company.
NHLD: 3.10 (+0.02)
National Holdings reports final fiscal 2015 year end results
M2 - Tue Dec 29, 4:51AM CST
National Holdings Corporation (NASDAQ:NHLD) on Tuesday declared net income of USD0.3m or USD0.02 per basic and diluted share for the fiscal year ended 30 September 2015, compared with net income of USD18.6m or USD1.51 per basic and $1.50 per diluted share in 2014.
NHLD: 3.10 (+0.02)
National Holdings Corporation Announces Fiscal 2015 Year End Results
BusinessWire - Mon Dec 28, 3:05PM CST
National Holdings Corporation (NASDAQ:NHLD) ("National" or the "Company", a leading full service independent brokerage, investment banking and asset management firm providing diverse services including tax preparation, today announced its financial results for the fiscal year ended September 30, 2015.
NHLD: 3.10 (+0.02)
National Holdings Corporation Schedules Fiscal 2015 Earnings Release and Conference Call
BusinessWire - Thu Dec 24, 8:42AM CST
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company" announced today that it will report its fiscal 2015 financial results on Monday, December 28, 2015 after the close of the financial markets. Management will host a conference call to discuss the operating and financial results and take investor questions at 9:00am ET on Tuesday, December 29, 2015.
NHLD: 3.10 (+0.02)
Tonix Pharmaceuticals Completes $10 Million Public Offering of Common Stock
GlobeNewswire - Tue Jun 21, 11:00AM CDT
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) (Tonix), today announced the closing of its previously announced underwritten public offering of 5,000,000 shares of its common stock. The shares were sold at the public offering price of $2.00 per share, bringing the aggregate gross proceeds from the offering to $10 million, before deducting underwriting discounts and commissions and other offering expenses. The financing was led by healthcare focused institutional investors.
TNXP: 2.16 (+0.03), NHLD: 3.10 (+0.02)
Champions Oncology, Inc. Announces Closing of Public Offering of Common Stock
PR Newswire - Wed Jun 15, 11:00AM CDT
Champions Oncology, Inc. (NASDAQ: CSBR), or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the closing of its previously announced underwritten public offering of 2,000,000 registered shares of its common stock, par value $0.001 per share, at an offering price of $2.25 per share. In addition, the Company announced today the partial exercise of the over-allotment option granted to the underwriter to purchase an additional 258,749 shares of its common stock at the public offering price. All of the shares have been offered by the Company. The shares of Champions Oncology, Inc. are currently trading on NASDAQ under the symbol "CSBR".
CSBR: 2.22 (+0.02), NHLD: 3.10 (+0.02)
Champions Oncology, Inc. Announces Pricing of Public Offering of Common Stock
PR Newswire - Thu Jun 09, 6:30PM CDT
Champions Oncology, Inc. (NASDAQ: CSBR), or the "Company", a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs, today announced the pricing of its previously announced underwritten public offering. The Company is offering 2,000,000 registered shares of its common stock, par value $0.001 per share, at an offering price of $2.25 per share. In addition, Champions Oncology, Inc. has granted the underwriter a 45-day over-allotment option to purchase up to 300,000 additional shares of common stock at the public offering price. All of the shares are being offered by the Company. The shares of Champions Oncology, Inc. are currently trading on NASDAQ under the symbol "CSBR".
CSBR: 2.22 (+0.02), NHLD: 3.10 (+0.02)
Interstate Batteries and Aqua Metals Form Strategic Partnership
GlobeNewswire - Thu May 19, 7:30AM CDT
Aqua Metals, Inc. (NASDAQ:AQMS) (Aqua Metals), which is commercializing a non-polluting electrochemical lead recycling technology called AquaRefining(TM), today announced the signing of definitive agreements with Interstate Batteries. Interstate Batteries is the No. 1 replacement battery brand, the largest independent battery distribution system in North America and the country's leading battery recycler.
AQMS: 12.20 (+0.29), NHLD: 3.10 (+0.02)
Scott K. Stucky Appointed Executive Vice-President of Software & Data Services at SettlementOne
PR Newswire - Wed May 18, 7:17AM CDT
Sackett National Holdings, Inc. (SNH), a leading provider of lending data, energy, employment screening and automotive products and services, today announced that Scott K. Stucky has been appointed Executive Vice-President, Software & Data Solutions, for SNH financial subsidiary SettlementOne.
NHLD: 3.10 (+0.02)
National Holding Corporation Announces Fiscal Second Quarter 2016 Financial Results
BusinessWire - Mon May 16, 4:01PM CDT
National Holding Corporation (NASDAQ:NHLD) ("National" or the "Company"
, a leading full service independent brokerage, investment banking and asset management firm providing diverse services including tax preparation & accounting services, today announced its financial results for the fiscal second quarter 2016 ended March 31, 2016. NHLD: 3.10 (+0.02)
National Holdings Corporation Schedules Fiscal 2016 Second Quarter Earnings Release and Conference Call
BusinessWire - Wed May 11, 7:00AM CDT
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company"
announced today that it will report its fiscal 2016 second quarter financial results on Monday, May 16, 2016 after the close of the financial markets. Management will host a conference call to discuss the operating and financial results and take investor questions at 9:00am ET on Tuesday, May 17, 2016. NHLD: 3.10 (+0.02)
Fortress Biotech Reports First Quarter 2016 Financial Results and Recent Corporate Highlights
GlobeNewswire - Tue May 10, 4:10PM CDT
Fortress Biotech, Inc. (NASDAQ:FBIO) ("Fortress"
, a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced its financial results and recent corporate highlights for the quarter ended March 31, 2016. FBIO: 2.89 (+0.15), NHLD: 3.10 (+0.02)
Fortress Biotech and National Holdings Announce Agreement
Marketwired - Thu Apr 28, 7:50AM CDT
National Holdings Corporation (NASDAQ: NHLD) ("National Holdings" or "NHLD"
, a full-service investment banking and asset management firm, and Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress" or "FBIO", a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, announce today that the two firms have entered into a definitive agreement (the "Agreement" pursuant to which Fortress will offer to purchase, through its wholly owned subsidiary, FBIO Acquisition, Inc., up to 100% of the shares of National Holdings at $3.25 per share in cash. The offer price represents a premium of ~44% over the closing price of NHLD common stock on April 27, 2016, the last trading day prior to today's announcement. FBIO: 2.89 (+0.15), NHLD: 3.10 (+0.02)
Resonant Inc. Announces Closing of Private Placement Raising Approximately $6 million in Gross Proceeds
BusinessWire - Tue Apr 26, 6:30AM CDT
Resonant Inc. (NASDAQ: RESN), a designer of filters for radio frequency, or RF, front-ends that specializes in delivering designs for difficult bands and complex requirements, today announced it has closed its previously announced private placement of units (the Offering) with various institutional and individual accredited investors and certain of the Company's officers and directors. Resonant raised gross proceeds of approximately $6 million in the Offering.
RESN: 4.07 (-0.04), NHLD: 3.10 (+0.02)
Resonant Inc. Announces Signing of Securities Purchase Agreement to Raise up to $6 Million in Gross Proceeds
BusinessWire - Fri Apr 22, 6:30AM CDT
Resonant Inc. (NASDAQ: RESN), a developer of innovative filter designs for radio frequency front-ends (RFFEs) for the mobile device industry, today announced it has entered into a definitive agreement with various institutional and individual accredited investors and certain of its officers and directors to raise gross proceeds of up to $6 million in a private placement of units at a per-unit price of $2.985 (the Offering).
RESN: 4.07 (-0.04), NHLD: 3.10 (+0.02)
Imprimis Pharmaceuticals Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares
PR Newswire - Wed Mar 16, 3:05PM CDT
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), ("Imprimis" or the "company"
, a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, announced today that it has completed the previously announced public offering of common stock. Imprimis sold 2.9 million shares in the offering and an additional 435,000 common shares upon the full exercise by the underwriters of their over-allotment option. The offering price was $3.60 per share, and the gross proceeds to Imprimis from the sale of shares, including the over-allotment option, were $12 million, before deducting underwriting expenses. NHLD: 3.10 (+0.02), IMMY: 3.85 (+0.05)
Imprimis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
PR Newswire - Fri Mar 11, 7:45AM CST
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), ("Imprimis" or the "company"
, a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, announced today the pricing of an underwritten public offering of 2.9 million shares of its common stock at a price to the public of $3.60 per share, before underwriting discounts. In addition, the company has granted the underwriters the option, exercisable for 45 days, to purchase an additional 435,000 shares of its common stock to cover over-allotments. The offering is expected to close on or about March 16, 2016, subject to satisfaction of customary closing conditions. NHLD: 3.10 (+0.02), IMMY: 3.85 (+0.05)
Imprimis Pharmaceuticals Announces Proposed Public Offering of Common Stock
PR Newswire - Thu Mar 10, 3:05PM CST
Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), ("Imprimis" or the "company"
, a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, announced today a proposed underwritten public offering of its common stock, subject to market and other conditions. In connection with the offering, the company intends to grant the underwriters the option, exercisable for 45 days, to purchase additional shares equal to up to 15% of the aggregate number of shares sold in the offering to cover over-allotments. NHLD: 3.10 (+0.02), IMMY: 3.85 (+0.05)
National Holdings Corporation Comments on Acquisition Offers
BusinessWire - Wed Jan 27, 8:00AM CST
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company"
, a full-service investment banking and asset management firm, provided the following comments regarding the two acquisition offers it had previously received during the final two months of 2015. NHLD: 3.10 (+0.02)
National Holdings expands its Investment Banking team with three investment bankers
M2 - Mon Jan 11, 7:27AM CST
National Holdings Corporation (NASDAQ:NHLD) revealed on Friday that it hired three investment bankers, Sagiv Shiv, S Quintus von Bonin and Ivan Saval to expand its M&A and advisory services capabilities.
NHLD: 3.10 (+0.02)
National Holdings Corporation Expands Its Investment Banking Team
BusinessWire - Fri Jan 08, 8:00AM CST
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company"
, a full-service investment banking and asset management firm, announced today that it has hired three investment bankers, Sagiv Shiv, S. Quintus von Bonin and Ivan Saval, greatly expanding its M&A and advisory services capabilities in order to continue to better serve our corporate clients and their needs. All of the bankers were previously employed by INTL FCStone Financial Inc., the securities business of INTL FCStone Inc. and collectively bring 75 years of industry experience to the Company. NHLD: 3.10 (+0.02)
National Holdings reports final fiscal 2015 year end results
M2 - Tue Dec 29, 4:51AM CST
National Holdings Corporation (NASDAQ:NHLD) on Tuesday declared net income of USD0.3m or USD0.02 per basic and diluted share for the fiscal year ended 30 September 2015, compared with net income of USD18.6m or USD1.51 per basic and $1.50 per diluted share in 2014.
NHLD: 3.10 (+0.02)
National Holdings Corporation Announces Fiscal 2015 Year End Results
BusinessWire - Mon Dec 28, 3:05PM CST
National Holdings Corporation (NASDAQ:NHLD) ("National" or the "Company"
, a leading full service independent brokerage, investment banking and asset management firm providing diverse services including tax preparation, today announced its financial results for the fiscal year ended September 30, 2015. NHLD: 3.10 (+0.02)
National Holdings Corporation Schedules Fiscal 2015 Earnings Release and Conference Call
BusinessWire - Thu Dec 24, 8:42AM CST
National Holdings Corporation (NASDAQ:NHLD) ("National Holdings" or the "Company"
announced today that it will report its fiscal 2015 financial results on Monday, December 28, 2015 after the close of the financial markets. Management will host a conference call to discuss the operating and financial results and take investor questions at 9:00am ET on Tuesday, December 29, 2015. NHLD: 3.10 (+0.02)
